Biomerica Inc financial data

Symbol
BMRA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
17571 Von Karman Avenue, Irvine, CA
State of incorporation
Delaware
Fiscal year end
May 31
Latest financial report
10-K - Q2 2024 - Aug 28, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 495 % -7.1%
Quick Ratio 106 % -10.3%
Debt-to-equity 29.2 % -6.01%
Return On Equity -69.2 % +19.4%
Return On Assets -53.6 % +18.2%
Operating Margin -118 % +13.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.8M shares 0%
Common Stock, Shares, Outstanding 16.8M shares 0%
Entity Public Float 14.5M USD -66%
Common Stock, Value, Issued 1.35M USD 0%
Weighted Average Number of Shares Outstanding, Basic 16.8M shares +18.8%
Weighted Average Number of Shares Outstanding, Diluted 16.8M shares +18.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.42M USD +1.42%
Revenue from Contract with Customer, Excluding Assessed Tax 5.42M USD +1.42%
Cost of Revenue 4.8M USD -1.82%
Research and Development Expense 1.49M USD -5.87%
Operating Income (Loss) -6.37M USD +11.9%
Nonoperating Income (Expense) 431K USD +222%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.94M USD +16.3%
Income Tax Expense (Benefit) 42K USD -17.6%
Net Income (Loss) Attributable to Parent -5.98M USD +16.3%
Earnings Per Share, Basic -0.36 USD/shares +28%
Earnings Per Share, Diluted -0.36 USD/shares +28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.17M USD -57.1%
Accounts Receivable, after Allowance for Credit Loss, Current 947K USD +31.2%
Inventory, Net 2.38M USD +15.6%
Assets, Current 7.73M USD -39.6%
Property, Plant and Equipment, Net 201K USD -5.63%
Operating Lease, Right-of-Use Asset 742K USD -28.3%
Intangible Assets, Net (Excluding Goodwill) 212K USD +28.5%
Other Assets, Noncurrent 203K USD +157%
Assets 9.25M USD -36%
Accounts Payable, Current 288K USD -16.3%
Employee-related Liabilities, Current 655K USD -5.89%
Accrued Liabilities, Current 850K USD +55.1%
Liabilities, Current 2.2M USD +13.3%
Operating Lease, Liability, Noncurrent 459K USD -41.5%
Liabilities 2.66M USD -2.45%
Accumulated Other Comprehensive Income (Loss), Net of Tax -102K USD +7.27%
Retained Earnings (Accumulated Deficit) -48.2M USD -14.2%
Stockholders' Equity Attributable to Parent 6.59M USD -43.8%
Liabilities and Equity 9.25M USD -36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.67M USD -6.42%
Net Cash Provided by (Used in) Financing Activities 1.78M USD +121%
Net Cash Provided by (Used in) Investing Activities -63K USD -85.3%
Common Stock, Shares Authorized 25M shares 0%
Common Stock, Shares, Issued 16.8M shares 0%
Common Stock, Par or Stated Value Per Share 0.08 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.73M USD -1196%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.35M USD -67.1%
Deferred Tax Assets, Valuation Allowance 10.4M USD +16%
Deferred Tax Assets, Gross 10.4M USD +16%
Operating Lease, Liability 785K USD -27.4%
Payments to Acquire Property, Plant, and Equipment 21K USD -38.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.97M USD +16.8%
Lessee, Operating Lease, Liability, to be Paid 842K USD -29.8%
Operating Lease, Liability, Current 326K USD +9.76%
Lessee, Operating Lease, Liability, to be Paid, Year Two 376K USD +2.73%
Lessee, Operating Lease, Liability, to be Paid, Year One 365K USD +2.53%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 57K USD -51.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 101K USD -73.1%
Deferred Tax Assets, Operating Loss Carryforwards 6.66M USD +14.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 4.43M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 101K USD -73.7%
Operating Lease, Payments 87K USD +1.16%
Additional Paid in Capital 53.5M USD +1.59%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 18K USD 0%
Depreciation, Depletion and Amortization 76K USD -77.6%
Deferred Tax Assets, Net of Valuation Allowance 8.09M USD
Share-based Payment Arrangement, Expense 1.05M USD -15.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares